Healthcare provider profile · identity verified

Anuj Vineet More, M.D.

Internal Medicine · LOUISVILLE, KY · NPI 1649331752

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	551	167
Prednisone	Prednisone	384	179
Albuterol Sulfate Hfa	Albuterol Sulfate	333	113
Amlodipine Besylate	Amlodipine Besylate	330	97
Atorvastatin Calcium	Atorvastatin Calcium	293	97
Pantoprazole Sodium	Pantoprazole Sodium	271	89
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	264	58
Lisinopril	Lisinopril	236	76
Metformin Hcl	Metformin Hcl	230	71
Gabapentin	Gabapentin	200	59
Metoprolol Succinate	Metoprolol Succinate	184	64
Tizanidine Hcl	Tizanidine Hcl	180	73
Carvedilol	Carvedilol	167	54
Losartan Potassium	Losartan Potassium	163	53
Levothyroxine Sodium	Levothyroxine Sodium	161	46
Omeprazole	Omeprazole	153	49
Alendronate Sodium	Alendronate Sodium	147	50
Furosemide	Furosemide	137	46
Glipizide	Glipizide	136	45
Fluticasone Propionate	Fluticasone Propionate	128	50
Trazodone Hcl	Trazodone Hcl	123	38
Cefdinir	Cefdinir	122	89
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	122	43
Meloxicam	Meloxicam	122	62
Sertraline Hcl	Sertraline Hcl	120	39
Vitamin D2	Ergocalciferol (Vitamin D2)	116	49
Duloxetine Hcl	Duloxetine Hcl	111	37
Clopidogrel	Clopidogrel Bisulfate	109	32
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	109	44
Azithromycin	Azithromycin	108	93
Hydrochlorothiazide	Hydrochlorothiazide	108	44
Tamsulosin Hcl	Tamsulosin Hcl	104	33
Doxycycline Monohydrate	Doxycycline Monohydrate	99	83
Allopurinol	Allopurinol	88	29
Diclofenac Sodium	Diclofenac Sodium	86	49
Metoprolol Tartrate	Metoprolol Tartrate	80	29
Glipizide Er	Glipizide	79	27
Hydralazine Hcl	Hydralazine Hcl	79	30
Spironolactone	Spironolactone	76	34
Isosorbide Mononitrate Er	Isosorbide Mononitrate	74	23
Potassium Chloride	Potassium Chloride	72	24
Finasteride	Finasteride	71	23
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	68	57
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	63	suppressed
Ondansetron Hcl	Ondansetron Hcl	54	23
Oxybutynin Chloride	Oxybutynin Chloride	54	18
Triamcinolone Acetonide	Triamcinolone Acetonide	54	30
Fluoxetine Hcl	Fluoxetine Hcl	52	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	18
Metformin Hcl Er	Metformin Hcl	48	15
Atenolol	Atenolol	47	12
Montelukast Sodium	Montelukast Sodium	46	14
Eliquis	Apixaban	44	18
Symbicort	Budesonide/Formoterol Fumarate	44	13
Mirtazapine	Mirtazapine	43	13
Naproxen	Naproxen	41	16
Warfarin Sodium	Warfarin Sodium	40	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	39	suppressed
Alprazolam	Alprazolam	38	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	36	14
Dropsafe Prep Pads	Alcohol Antiseptic Pads	34	14
Famotidine	Famotidine	33	15
Citalopram Hbr	Citalopram Hydrobromide	31	11
Pravastatin Sodium	Pravastatin Sodium	31	12
Ropinirole Hcl	Ropinirole Hcl	31	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	28	suppressed
Ibuprofen	Ibuprofen	28	12
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Bupropion Xl	Bupropion Hcl	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Ondansetron Odt	Ondansetron	26	16
Sildenafil Citrate	Sildenafil Citrate	26	suppressed
Buspirone Hcl	Buspirone Hcl	25	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	18
Hydroxyzine Hcl	Hydroxyzine Hcl	25	12
Escitalopram Oxalate	Escitalopram Oxalate	24	suppressed
Primidone	Primidone	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Ezetimibe	Ezetimibe	22	suppressed
Fluconazole	Fluconazole	22	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	15
Bumetanide	Bumetanide	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	12
Metolazone	Metolazone	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Pregabalin	Pregabalin	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Baclofen	Baclofen	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Azelastine Hcl	Azelastine Hcl	16	13
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Linzess	Linaclotide	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Paxlovid	Nirmatrelvir/Ritonavir	16	14
Risperidone	Risperidone	16	suppressed
Digoxin	Digoxin	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Felodipine Er	Felodipine	15	11
Lorazepam	Lorazepam	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	14	suppressed
Promethazine Hcl	Promethazine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	11
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Clonidine	Clonidine	12	suppressed
Ibu	Ibuprofen	12	suppressed
Metronidazole	Metronidazole	12	12
Venlafaxine Hcl	Venlafaxine Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Topiramate	Topiramate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error